SCHEMBL1965147

SCHEMBL1965147

O=[C]c1cccc([C]=O)c1[C]=O

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7920276 0.86 CYP3A4 (0.30) CYP3A4
SCHEMBL10885088 0.82 CYP3A4 (0.36) CYP3A4
SCHEMBL102469 0.82 CYP1A2 (0.36)
SCHEMBL335267 0.82 CA2 (0.38) CYP3A4
SCHEMBL1698298 0.82 TSHR (0.39) CYP3A4
SCHEMBL9242790 0.82
SCHEMBL7705802 0.82 CES2 (0.36)
SCHEMBL9022619 0.80
SCHEMBL4605071 0.80 MEN1 (0.31)
SCHEMBL1049567 0.78 GABRA1 (0.45) CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9382437-B2 Aryltricarboxyl-attached pigment-based inks with improved slewing decap HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) 2016-07-05 US claimed
EP-1943317-B1 ARYLTRICARBOXYL-ATTACHED PIGMENT-BASED INKS WITH IMPROVED SLEWING DECAP HEWLETT PACKARD DEVELOPMENT CO (US) 2008-12-24 EP claimed
EP-1943317-A1 ARYLTRICARBOXYL-ATTACHED PIGMENT-BASED INKS WITH IMPROVED SLEWING DECAP Hewlett-Packard Development Company, L.P. (US) 2008-07-16 EP claimed
WO-2007040757-A1 ARYLTRICARBOXYL-ATTACHED PIGMENT-BASED INKS WITH IMPROVED SLEWING DECAP HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) 2007-04-12 WO claimed
US-20070076068-A1 Aryltricarboxyl-attached pigment-based inks with improved slewing decap HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. 2007-04-05 US claimed
EP-0517658-B1 Stabilisation of polymeric organic materials by using synergistic mixtures comprising sterically hindered cyclic amines and derivatives of 3-pyrazolidinone or 1,2,4-triazolidine-3,5-dione CIBA GEIGY AG (CH) 1997-01-29 EP claimed
EP-0548015-B1 Tetramethylpiperidine compounds for use as stabilisers for organic materials CIBA GEIGY AG (CH) 1996-01-03 EP claimed
US-5457143-A Light, heat and oxydiation resistance CIBA-GEIGY CORPORATION (US) 1995-10-10 US claimed
US-5416216-A Tetramethylpiperidine compounds for use as stabilizers for organic materials CIBA-GEIGY CORPORATION (US) 1995-05-16 US claimed
US-5310767-A FOR POLYMERS CIBA-GEIGY CORPORATION (US) 1994-05-10 US claimed
EP-0548015-A1 Tetramethylpiperidine compounds for use as stabilisers for organic materials CIBA-GEIGY AG (CH) 1993-06-23 EP claimed
US-5210118-A Phenyl-3-Pyrazolidinones CIBA-GEIGY CORPORATION (US) 1993-05-11 US claimed
EP-0523007-A1 Novel tetramethylpiperidine compounds for use as stabilisers for organic materials CIBA-GEIGY AG (CH) 1993-01-13 EP claimed
EP-0517658-A1 Stabilisation of polymeric organic materials by using synergistic mixtures comprising sterically hindered cyclic amines and derivatives of 3-pyrazolidinone or 1,2,4-triazolidine-3,5-dione CIBA-GEIGY AG (CH) 1992-12-09 EP claimed
EP-0462068-A2 A method for stabilizing synthetic thermoplastic materials against thermal degradation CIBA-GEIGY AG (CH) 1991-12-18 EP claimed
US-4202816-A ENOL-PIPERIDINE METAL COMPLEXES CIBA-GEIGY CORPORATION (US) 1980-05-13 US claimed
US-20240209160-A1 POLYMERIC DISPERSANTS FROM PHENYL GLYCIDYL ETHER STEPAN COMPANY 2024-06-27 US disclosed
US-11939434-B2 Polymeric dispersants from phenyl glycidyl ether STEPAN COMPANY (US) 2024-03-26 US disclosed
US-4803234-A Piperidine compounds and their use as anti-oxidative, light or thermal induced degradation agents CIBA-GEIGY CORPORATION (US) 1989-02-07 US disclosed
US-4202816-A ENOL-PIPERIDINE METAL COMPLEXES CIBA-GEIGY CORPORATION (US) 1980-05-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240209160-A1 POLYMERIC DISPERSANTS FROM PHENYL GLYCIDYL ETHER TYR, PAOX, NAPEPLD CYP3A4 1025/4885
US-11939434-B2 Polymeric dispersants from phenyl glycidyl ether TYR, PAOX, NAPEPLD CYP3A4 1025/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.